Skip to content
Use caution Medical device recall · FDA · Published August 5, 2021

Armstrong Medical AMSORB PLUS G-CAN 1.0L: Risk of inadequate ventilation during anesthesia

Armstrong Medical recalls AMSORB PLUS PREFILLED G-CAN 1.0L carbon dioxide absorbent canisters with product codes AMAB3801 and AMAB3801GE due to potential high resistance to gas flow during anesthesia, which could delay treatment. Affected units were sold from specific production lots.

🇺🇸 FDA recall #Z-2433-2021Medical deviceArmstrong Medical ›
Take action

Contact the company

Recalling firmArmstrong Medical Services LimitedNewBridge Road, Wattstown Business Park · Coleraine, Ireland
✎ GovInfoNow plain-language explainer

What happened, in plain English

Armstrong Medical is recalling certain carbon dioxide absorbent canisters used in anesthesia because some may cause high resistance to gas flow during patient ventilation, potentially delaying critical treatment. This could be serious for patients under anesthesia who require precise breathing support. Read more at govinfonow.com/recall/62063-armstrong-medical-amsorb-plus-g-can-1-0l-risk-of.

Source Summary by GovInfoNow · govinfonow.com/recall/62063-armstrong-medical-amsorb-plus-g-can-1-0l-risk-of · Updated August 19, 2026 · FDA enforcement record: FDA #Z-2433-2021

Cite this page

“Armstrong Medical AMSORB PLUS G-CAN 1.0L: Risk of inadequate ventilation during anesthesia.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/62063-armstrong-medical-amsorb-plus-g-can-1-0l-risk-of. Based on FDA recall #Z-2433-2021 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-2433-2021%22&limit=1).

Why it’s dangerous

The canisters may develop unexpected high resistance to gas flow during clinical use, which could prevent proper ventilation of an anesthetized patient. This might delay critical treatment if the patient's breathing becomes inadequate. Not all defective units will be detected by the pre-use test.

Who’s affected

Healthcare professionals using the AMSORB PLUS G-CAN 1.0L during anesthesia procedures are most at risk, particularly when the device fails to maintain adequate ventilation for patients.

How to tell if you have this one

Check for product codes AMAB3801 or AMAB3801GE on the canister. Affected units were sold with specific production lots listed in the recall notice, including dates from 010321F51 through 310521F511.

  • Brand
    Armstrong Medical
  • Category
    Medical device
Based on the official FDA remedy

What to do — step by step

  1. Check Canister Code

    Look for product codes AMAB3801 or AMAB3801GE on the canister to determine if it's affected.

  2. Verify Production Lot

    Confirm the canister's production lot number matches the list of affected lots provided in the recall notice.

Where it went and when

Where it was distributed

Distributed nationwide, and outside the U.S.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Worldwide distribution - US Nationwide distribution and the countries of Austria, Belgium, Canada, Finland, Germany, Greece, Iceland, India, Ireland, Israel, Italy, Japan, Kuwait, Portugal, United Kingdom.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide, and outside the U.S.

Recall timeline

FDA terminated this recall 3.1 years after the firm started it.

1. Firm started the recall: Aug 5, 202112. FDA classified it Class I: Sep 13, 202123. Published in FDA’s Enforcement Report: Sep 22, 202134. FDA terminated the recall: Sep 17, 2024420212024
  1. Firm started the recall
  2. FDA classified it Class I
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-2433-2021 (August 5, 2021) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-2433-2021 to see it in context.
  • Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA